Who are Micro-K 10's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Acid Reflux Relief, Potassium Iodide, IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER, potassium bromide.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/potassium-chloride.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Micro-K 10 — Competitive Intelligence Brief

Micro-K 10 (POTASSIUM CHLORIDE) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: potassium chloride. Area: Metabolic.

marketed potassium chloride Carbonic anhydrase 4 Metabolic Small molecule Live · refreshed every 30 min

Target snapshot

Micro-K 10 (POTASSIUM CHLORIDE) — Nesher Pharms. Micro-K 10 works by replenishing potassium levels in the body, which helps regulate muscle and nerve function.

Comparator set (4 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Micro-K 10 TARGET	POTASSIUM CHLORIDE	Nesher Pharms	marketed	potassium chloride	Carbonic anhydrase 4	1965-01-01
Acid Reflux Relief	Sodium Phosphate, Dibasic, Heptahydrate	Pfizer	marketed	Non-Standardized Plant Allergenic Extract [EPC]	Carbonic anhydrase 4	1983-01-01
Potassium Iodide	POTASSIUM IODIDE	Roxane	marketed		Carbonic anhydrase 4	1979-01-01
IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM PHOSPHATE, MONOBASIC ANHYDROUS	OTSUKA ICU MEDCL	marketed		Carbonic anhydrase 4
potassium bromide	potassium bromide		marketed		Carbonic anhydrase 4

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2028-06-22 — Acid Reflux Relief · 7687075 · US
2039-03-07 — Micro-K 10 · 12539314 · Formulation · US

Sponsor landscape (potassium chloride class)

Nesher Pharms · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Micro-K 10 — Competitive Intelligence Brief. https://druglandscape.com/ci/potassium-chloride. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab